ICUCW SeaStar Medical Holding Corporation - Warrant

$0.02
Price · Aug 19, 2026
Fundamentals as of Aug 12, 2026

ICUCW Stock Snapshot Price, market cap, P/E, EPS, ROE, debt/equity, 52-week range

Price
$0.02
Market Cap
P/E (TTM)
EPS (TTM)
$-6.63
Revenue (TTM)
$1M
Div Yield
ROE
-176.6%
Debt/Equity
0.1
52W Range
$0 – $0

ICUCW Stock Price Chart Daily OHLCV with technical indicators — pan, zoom, and customize your view

10-Year Performance Revenue, net income, margins and EPS trends

Revenue & Net Income $1M
3-point trend, +1234000.00
2023-12-31 2025-12-31
EPS $-6.63
4-point trend, -952.4%
2021-12-31 2024-12-31
Free Cash Flow
Margins -984.6%
2025-12-31 2025-12-31

Valuation P/E, P/S, P/B, EV/EBITDA ratios — is the stock expensive or cheap?

Metric
5Y trend
ICUCW
Peer Median

Profitability Gross, operating and net margins; ROE, ROA, ROIC

Metric
5Y trend
ICUCW
Peer Median
Gross Margin
95.7%
Operating Margin
-986.6%
Net Profit Margin
-984.6%
ROA
2-point trend, -92350.0%
-129.2%
ROE
2-point trend, -24778.9%
-176.6%
ROIC
-111.3%

Financial Health Debt, liquidity, solvency — balance sheet strength

Metric
5Y trend
ICUCW
Peer Median
Debt / Equity
0.1
Current Ratio
3.6
Quick Ratio
2-point trend, +2284.8%
3.3

Growth Revenue, EPS and net income growth: YoY, 3Y CAGR, 5Y CAGR

Metric
5Y trend
ICUCW
Peer Median
Revenue YoY
3-point trend, +1234000.00
814.1%

Per Share Metrics EPS, book value per share, cash flow per share, dividend per share

Metric
5Y trend
ICUCW
Peer Median
EPS (Diluted)
4-point trend, -952.4%
$-6.63

Capital Efficiency Asset turnover, inventory turnover, receivables turnover

Metric
5Y trend
ICUCW
Peer Median

Full Fundamentals All metrics by year — income statement, balance sheet, cash flow

Income Statement 18
Annual Income Statement data for ICUCW
Metric Trend 202520242023
Revenue 3-point trend, +1234000.00 $1M $135.0K $0
Cost of Revenue 3-point trend, +53000.00 $53.0K $0 $0
Gross Profit 3-point trend, +1181000.00 $1M $135.0K $0
R&D Expense 3-point trend, +25.9% $8M $9M $6M
SG&A Expense 3-point trend, -29.1% $6M $9M $8M
Operating Expenses 3-point trend, -6.0% $13M $18M $14M
Operating Income 3-point trend, +14.3% $-12M $-18M $-14M
Interest Expense 2-point trend, -77.4% · $244.0K $1M
Interest Income 3-point trend, +325000.00 $325.0K $101.0K $0
Other Non-op 3-point trend, +100.2% $28.0K $-7M $-12M
Pretax Income 3-point trend, +53.7% $-12M $-25M $-26M
Income Tax 3-point trend, +3000.00 $3.0K $3.0K $0
Net Income 3-point trend, +53.7% $-12M $-25M $-26M
EPS (Basic) 3-point trend, +80.6% $-5.86 $-66.33 $-30.26
EPS (Diluted) 2-point trend, +78.1% · $-6.63 $-30.26
Shares (Basic) 3-point trend, +139.2% 2,073,087 374,356 866,813
Shares (Diluted) 2-point trend, +331.9% · 3,743,554 866,813
EBITDA $-12M · ·
Balance Sheet 20
Annual Balance Sheet data for ICUCW
Metric Trend 202520242023
Cash & Equivalents 3-point trend, +6706.8% $12M $2M $176.0K
Receivables 3-point trend, +237000.00 $237.0K $112.0K $0
Inventory 2-point trend, +66000.00 $66.0K $0 ·
Prepaid Expense 3-point trend, -39.2% $1M $2M $2M
Current Assets 3-point trend, +488.4% $14M $4M $2M
Other Non-current Assets 2-point trend, -35.2% $578.0K $892.0K ·
Total Assets 3-point trend, +303.0% $14M $5M $4M
Accounts Payable 3-point trend, -78.3% $948.0K $3M $4M
Accrued Liabilities 3-point trend, +48.9% $2M $3M $2M
Short-term Debt 3-point trend, -7.1% $525.0K $574.0K $565.0K
Current Liabilities 3-point trend, -71.3% $4M $7M $13M
Total Liabilities 3-point trend, -78.5% $4M $7M $17M
Long-term Debt · · $4M
Total Debt $525.0K · ·
Common Stock 3-point trend, +300.0% $4.0K $2.0K $1.0K
Paid-in Capital 3-point trend, +60.7% $162M $137M $101M
Retained Earnings 3-point trend, -32.2% $-152M $-140M $-115M
Stockholders' Equity 3-point trend, +175.1% $10M $-2M $-14M
Liabilities + Equity 3-point trend, +303.0% $14M $5M $4M
Shares Outstanding 3-point trend, +90.7% 3,844,613 650,639 2,016,045
Cash Flow 7
Annual Cash Flow data for ICUCW
Metric Trend 202520242023
Stock-based Comp 3-point trend, -67.7% $624.0K $887.0K $2M
Operating Cash Flow 3-point trend, -32.2% $-14M $-16M $-10M
Debt Issued · $1M ·
Stock Issued 3-point trend, +240.1% $16M $17M $5M
Net Stock Activity $16M · ·
Financing Cash Flow 3-point trend, +128.2% $24M $18M $10M
Net Change in Cash 2-point trend, +518.4% $10M $2M ·
Profitability 8
Annual Profitability data for ICUCW
Metric Trend 202520242023
Gross Margin 95.7% · ·
Operating Margin -986.6% · ·
Net Margin -984.6% · ·
Pretax Margin -984.4% · ·
EBITDA Margin -986.6% · ·
ROA -129.2% · ·
ROE -176.6% · ·
ROIC -111.3% · ·
Liquidity & Solvency 3
Annual Liquidity & Solvency data for ICUCW
Metric Trend 202520242023
Current Ratio 3.6 · ·
Quick Ratio 3.3 · ·
Debt / Equity 0.1 · ·
Efficiency 3
Annual Efficiency data for ICUCW
Metric Trend 202520242023
Asset Turnover 0.1 · ·
Inventory Turnover 1.6 · ·
Receivables Turnover 7.1 · ·
Per Share 3
Annual Per Share data for ICUCW
Metric Trend 202520242023
Book Value / Share $2.71 · ·
Cash / Share $3.12 · ·
EPS (TTM) 3-point trend, +90.9% $-2.75 $-6.63 $-30.26
Growth Rates 1
Annual Growth Rates data for ICUCW
Metric Trend 202520242023
Revenue YoY 814.1% · ·
Valuation (TTM) 2
Annual Valuation (TTM) data for ICUCW
Metric Trend 202520242023
Revenue TTM 3-point trend, +1234000.00 $1M $135.0K $0
Net Income TTM 3-point trend, +53.7% $-12M $-25M $-26M

Financial Statements Income statement, balance sheet, cash flow — annual, last 5 years

Income Statement
2025-12-312024-12-312023-12-312023-09-302023-06-30
Revenue $1M$135.0K$0
Gross Margin % 95.7%
Operating Margin % -986.6%
Net Income $-12M$-25M$-26M
Diluted EPS $-6.63$-30.26
Balance Sheet
2025-12-312024-12-312023-12-312023-09-302023-06-30
Debt / Equity 0.1
Current Ratio 3.6
Quick Ratio 3.3

My Metrics Your personal watchlist — selected rows from Full Fundamentals

📊

Pick the metrics that matter to you — click the ➕ next to any row in Full Fundamentals above.

Your selection is saved and follows you across all tickers.

Institutional owners (13F) 17 filers · $921K total · As of June 30, 2026

Institutions that report holding this stock in their quarterly SEC Form 13F. Long positions only; a single filer may appear twice for separate option legs. Large offsetting put/call legs typically reflect market-making or hedged inventory, not directional conviction.

Institutional activity — Q2 2026 vs prior quarter
New positions Exited positions Increased Decreased Net shares change
4 (+3 vs prior Q) 0 (-5 vs prior Q) 2 (+2 vs prior Q) 1 (0 vs prior Q) +111K

Compared to Q1 2026. SEC Form 13F filings are due within 45 days of quarter-end plus a short buffer for late filers — quarters still inside that window are skipped in favor of the most recent fully-reported pair.

Institution Value Shares % of tracked 13F Type
BOOTHBAY FUND MANAGEMENT, LLC $899,884 245,200 97.68% Shares
ATW SPAC MANAGEMENT LLC $6,645 245,200 0.72% Shares
GOLDMAN SACHS GROUP INC $3,657 211,381 0.40% Shares
Linden Advisors LP $3,511 218,073 0.38% Shares
LMR Partners LLP $2,163 125,000 0.23% Shares
CLEAR STREET LLC $929 46,690 0.10% Shares
Clear Street Group Inc. $808 46,690 0.09% Shares
TENOR CAPITAL MANAGEMENT Co., L.P. $692 40,000 0.08% Shares
EQUITEC PROPRIETARY MARKETS, LLC $618 35,700 0.07% Shares
Cruiser Capital Advisors, LLC $562 32,473 0.06% Shares
SUSQUEHANNA INTERNATIONAL GROUP, LLP $539 36,179 0.06% Shares
TWO SIGMA SECURITIES, LLC $421 24,322 0.05% Shares
MILLENNIUM MANAGEMENT LLC $389 22,500 0.04% Call option
StoneX Group Inc. $208 11,086 0.02% Shares
WOLVERINE ASSET MANAGEMENT LLC $192 11,081 0.02% Shares
UBS Group AG $14 801 0.00% Shares
Virtu Financial LLC $1 40,316 0.00% Shares

Company insiders 6 insiders · 2 officers · 4 directors

Insider Role Last activity Shares owned Buys 12m Sells 12m Net 12m
Eric Schlorff Chief Executive Officer July 1, 2026 A 50,140 0 0 $0
Kevin Chung Chief Medical Officer July 1, 2026 A 28,021 0 0 $0
Bernadette N Vincent Director July 1, 2026 A 8,200 0 0 $0
Jennifer A Baird Director July 1, 2026 A 10,620 0 0 $0
John Neuman Director July 1, 2026 A 16,200 0 0 $0
Kenneth Van Heel Director July 1, 2026 A 11,940 0 0 $0

Insiders from SEC Form 3/4/5 filings; net = open-market P/S only